Efectos adversos de la vacunación a personas con VIH/SIDA

• Autores: Alba María Vega Viyuela
• Localización: ENE Revista de Enfermería, ISSN-e 1988-348X, Nº. 9, 3, 2015
• Idioma: español
• DOI: 10.4321/S1988-348X2015000300006
• Enlaces
  • Texto completo
• Resumen
  • español

    Antecedentes: Las personas portadoras del Virus de Inmunodeficiencia Adquirida (VIH) representa un grupo de especial atención para su cuidado, dadas las condiciones de presentar un sistema inmunitario comprometido. Estas personas tienen mayor riesgo de sufrir infecciones y de sufrir efectos adversos derivados de la vacunación, por lo tanto, resulta de interés un estudio detallado de su vacunación. Metodología: Estudio descriptivo mediante una búsqueda bibliográfica. Resultados: 50 artículos que permiten una descripción detallada de las características de un conjunto de 14 vacunas para este grupo de personas. Conclusiones: La mayoría de las vacunas valoradas se recomiendan. La situación ideal es un recuento de CD4 sea >200 células/mm³ y con tratamiento antirretroviral.

  • English

    Background: HIV infected people are a special care group because they present a immune"compromised system. These people have higher risk of infection and suffer adverse effects from the vaccine, therefore, it's interesting a detailed study of the vaccine. Methodology: descriptive study through a literature search. Results: 50 articles allow a detailed description of the characteristics of a 14 vaccines set for this people group. Conclusion: the majority of vaccines are recommended. The CD4 count should be > 200 cells/mm³ and the HIV-infected people should take the antiretroviral treatment.

• Referencias bibliográficas
  • Ward, BJ. (2000). Vaccine adverse events in the new millennium: in there reason for concern?. boletín WHO. 11
  • Ministerio de Salud Pública español. (2004). Vacunas recomendadas en personas infectadas por el virus de la inmunodeficiencia humana. 71-73
  • Hussay, G.. (2004). Adverse Effects of Bacille Calmette-Guérin Vaccination in HIV-Positive Infants. Clinical Infectious Diseases. 38. 1334
  • Puthanakit, T.. (2005). Immune Reconstitution Syndrome Due to Bacillus Calmette-Guérin after Initiation of Antiretroviral Therapy in Children...
  • Waddel, RD.. (2000). Safety and Immunogenicity of a Five-Dose Series of Inactivated Mycobacterium vaccae Vaccination for the Prevention of...
  • Juzi, JT., Sidler, D., Moore, SW.. (2008). Surgical management of BCG vaccineinduced regional axillary lymphadenitis in HIV-infected children....
  • Bannister, C., Bennett, L., Carville, A., Azzopardi, P.. (2009). Evidence behind the WHO Guidelines: Hospital Care for Children: What is the...
  • Fordham von Reyn, C.. (2005). Routine Childhood Bacille Calmette Guerin Immunization and HIV Infection. Clinical Infectious Diseases. 42....
  • Hesseling, AC.. (2003). Danis Bacille Calmette-Guérin Vaccine-Induced Disease in Human Immunodeficiency Virus-Infected Children. Clinical...
  • Karpelowsky, JS., Alexsander, AG, Peek, SD., Millar, AJ., Rode, H.. (2008). Surgical complications of bacille Calmette-Guérin (BCG) infection...
  • Nuttal, JJ., Davies, MA., Hussey, GD., Eley, BS.. (2008). Bacillus Calmette-Guérin (BCG) vaccine-induced complications in children treated...
  • Scriba, TJ.. (2012). A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/or Mycobacterium tuberculosis -infected Adults....
  • Puthanakit, T, Aurpibul, L, Yoksan, S, Sirisanthana, T, Sirisanthana, V. (2007). Japanese encephalitis vaccination in HIV-infected children...
  • Veit, O.. (2009). Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV-infected Patients. Clinical Infectious Diseases. 48. 659-666
  • Thomas, RE., Lorenzetti, DL., Spragins, W., Jackson, D., Williamson, T.. (2012). The Safety of Yellow Fever Vaccine 17D or 17DD in Children,...
  • Barte, H., Horvath, TH., Rutherford, GW. (2014). Yellow fever vaccine for patients with HIV infection. The Chrocane Collaboration.
  • Weinberg, A. (2005). Antibody Responses to Hepatitis A Virus Vaccine in HIV-infected Children with Evidence of Immunologic Reconstitution...
  • Wallace, MR.. (2004). Safety and Immunogenicity of an Inactivated Hepatitis A Vaccine among HIV-infected Subjects. Clinical Infectous Diseases....
  • Kemper, CA.. (2003). Safety and Immunogenicity of Hepatitis A Vaccine in Human Immunodeciency Virus-Infected Patients: A Double-Blind, Randomized,...
  • (2011). From caracter to personality: Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects. Clinical...
  • Overton, ET.. (2010). Immune Response to Hepatitis B Vaccine in HIV-infected Subjects Using Granulocyte-Macrophage Colony-Stimulating Factor...
  • (2004). Division of AIDS table for grading the severity os adults and pediatric adverse events version 1.0.. 21
  • Ansaldi, F.. (2012). Phase 4 randomized trial of intradermal low-antigen-content inactivated influenza vaccine vs. standard-dose intramuscular...
  • Cooper, C.. (2012). High-level immunogenicity is achieved vaccine with adjuvanted pandemic H1N1 (2009) and improved with booster dosing in...
  • Crum-Cianflon, NF.. (2011). Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine in an Immunocompromised Population: A Prospective...
  • Noah McKittrick, MD.. (2013). Improved Immunogenicity With High-Dose Seasonal Influenza Vaccine in HIV-infected Persons. Annals of International...
  • Steffens, B.. (2011). Acceptance And tolerability of An Adjuvanted nH1n1 vaccine in HIV-infected patients In the cologne-Bonn cohort. European...
  • Leahy, TR., Goode, M, Lynam, P., Gavin, PJ., Butler, KM.. (2014). HIV virological suppression influences response to the AS03-adjuvanted monovalent...
  • Phongsamarta, W.. (2011). Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children. Vaccine. 29. 8711
  • Beck, CR., McKenzie, BC., Hashim, AB., Harris, RC.. (2012). Influenza Vaccination for Immunocompromised Patients: Systematic Review and Meta-analysis...
  • Ceravolo, A., Orsi, a., Parodi, V., Rosselli, R., Ansaldi, F.. (2013). Influenza vaccination in HIV-positive subjects: latest evidence and...
  • Vigano, A.. (2011). Long-Term Immunogenicity after One and Two Doses of a Monovalent MF59-Adjuvanted A/H1N1 Influenza Virus Vaccine Coadministered...
  • El Sahly Hana, M.. (2012). Higher Antigen Content Improves the Immune Response to 2009 H1N1 Influenza Vaccine in HIV-infected Adults: A Randomized...
  • Siberry, GK.. (2012). Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine in 2 to 10 Year-Old Human Immunodeficiency...
  • Siberry, GK.. (2010). Phase I/II, Open-Label Trial of Safety and Immunogenicity of Meningococcal (Groups A, C, Y, and W-135) Polysaccharide...
  • Rives, MT., Menéndez, JJ., Calderón, B., De José, M., Alvarado, F., Ruza, FJ.. (2008). Fallo de la vacuna antineumocócica conjugada en un...
  • Sogaard, Os.. (2010). Improving the Immunogenicity of Pneumococcal Conjugate Vaccine in HIV-infected Adults with a Toll-Like Receptor 9 Agonist...
  • French, N.. (2010). A trial of 7-valent Pneumococcal Conjugate Vaccine in HIV-infected Adults. N Engl J Med.. 362. 822
  • Lu, CL.. (2012). Impact of vaccination with seven-valent pneumococcal conjúgate vaccine on virologic and Immunologic outcomes among HIV-infected...
  • Myron, JL. (2011). Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine in HIV-Infected Children...
  • Sow, PS.. (2013). Safety and Immunogenicity of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine: A Randomized Trial in 10-25-Year-Old HIV...
  • Denny, L.. (2013). Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: A partially-blind...
  • Chitsike, I., Van Furth, R.. (1999). Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in...
  • American academy of pediatrics. (1999). Measles Immunizationin HIV-Infected Children. Pediatrics. 103. 1057-1060
  • Aurpibul, L., Puthanakit, T., Sirisanthana, T., Sirisanthana, V.. (2007). Response to Measles, Mumps, and Rubella Revaccination in HIV-Infected...
  • Scott, P., Moss, WJ., Gilani, Z., Low, N.. (2011). Measles Vaccination in HIV-Infected Children: Systematic Review and Meta-Analysis of Safety...
  • Abzug, MJ.. (2007). Pertussis Booster Vaccination in HIV-Infected Children Receiving Highly Active Antiretroviral Therapy. Pediatrics. 120....
  • Gershon, AA.. (2009). A phase i-ii study of live attenuated Varicella-Zoster virus vaccine to boost immunity in human immunodeficiency virus-infected...
  • Weinberg, A, Levin, MJ, MacGregor, RR. (2010). Safety and immunogenicity of a live attenuated varicella vaccine in VZV-seropositive HIV-infected...
  • Berkowitz, EM.. (2014). Safety and Immunogenicity of an Adjuvanted Herpes Zoster Subunit Candidate Vaccine in HIV-Infected Adults: Phase 1/2a...
  • Bartlett, JG.. (2003). Smallpox Vaccination and Patients with Human Immunodeficiency Virus Infection or Acquired Immunodeficiency Syndrome....